The grant opportunity CDC-RFA-CK-25-0125 is aimed at increasing awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States, under the direction of the Centers for Disease Control and Prevention (CDC) and the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). Alpha-gal Syndrome is an emerging condition that is not yet nationally notifiable, but this initiative seeks to improve public understanding and response. The focus is on three key strategies: conducting public health surveillance, educating both the public and healthcare providers, and disseminating the latest knowledge to stakeholders like public health agencies and researchers.

The funding is provided through a cooperative agreement, with an estimated total program funding of $2,250,000. Individual awards will range from $25,000 to $1,000,000, with up to three awards expected. Eligible applicants include a wide range of entities, including state and local governments, nonprofits, tribal organizations, institutions of higher education, and private businesses. There is no cost-sharing requirement.

The grant opportunity opens for applications in January 2025, with submissions due by March 10, 2025. Awards are anticipated to be announced by July 1, 2025, and projects will start on the same date.

This program will focus on improving public health surveillance in underserved areas, educating those at higher risk for tick encounters, and sharing current research to enhance patient care. For additional information or to explore applying, interested parties can contact Jeff Borchert at JBorchert@cdc.gov or call 970-221-6494.